Back to Dashboard
BSX · Healthcare

BOSTON SCIENTIFIC CORP

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
58
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. BOSTON SCIENTIFIC CORP is not currently in our model portfolio, but 10 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$65.4B
Industry
Medical Devices
Exchange
NYSE
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as…
10
Investors
2
New positions
4
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Viking Global Investors
Trust weight: 1.5×
New position
% of portfolio
0.6%
Position change
NEW
0.6% of Viking Global Investors's portfolio
Lone Pine Capital (Mandel)
Trust weight: 1.4×
New position
% of portfolio
0.1%
Position change
NEW
0.1% of Lone Pine Capital's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Increased +26%
% of portfolio
0.9%
Position change
+26%
0.9% of D.E. Shaw & Co's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +32%
% of portfolio
0.8%
Position change
+32%
0.8% of Millennium Management's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Increased +11%
% of portfolio
0.4%
Position change
+11%
0.4% of Tudor Investment's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +49%
% of portfolio
0.4%
Position change
+49%
0.4% of Point72's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −46%
% of portfolio
0.3%
Position change
−46%
0.3% of Citadel Advisors's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Decreased −21%
% of portfolio
0.1%
Position change
−21%
0.1% of Gotham Asset Mgmt's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −6%
% of portfolio
0.1%
Position change
−6%
0.1% of AQR Capital Management's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −41%
% of portfolio
0.0%
Position change
−41%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BOSTON SCIENTIFIC CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BOSTON SCIENTIFIC CORP or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API